Basic Information
| LncRNA/CircRNA Name | RPSAP52 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioblastoma |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot etc. |
| Sample | GBM tissues, cell line (U-373 MG) |
| Expression Pattern | up-regulated |
| Function Description | RPSAP52 was upregulated in GBM patients, and its high expression levels predicted poor survival. |
| Pubmed ID | 32368136 |
| Year | 2020 |
| Title | LncRNA RPSAP52 Upregulates TGF-?1 to Increase Cancer Cell Stemness and Predict Postoperative Survival in Glioblastoma |
External Links
| Links for RPSAP52 | GenBank HGNC NONCODE |
| Links for glioblastoma | OMIM COSMIC |